CH661745A5 - Application d'un procede a la production de suppresseur de reponse immunitaire humain. - Google Patents
Application d'un procede a la production de suppresseur de reponse immunitaire humain. Download PDFInfo
- Publication number
- CH661745A5 CH661745A5 CH805/83A CH80583A CH661745A5 CH 661745 A5 CH661745 A5 CH 661745A5 CH 805/83 A CH805/83 A CH 805/83A CH 80583 A CH80583 A CH 80583A CH 661745 A5 CH661745 A5 CH 661745A5
- Authority
- CH
- Switzerland
- Prior art keywords
- cells
- human
- srih
- production
- human cells
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 35
- 238000000034 method Methods 0.000 title claims description 16
- 230000028993 immune response Effects 0.000 title claims description 7
- 230000008569 process Effects 0.000 title description 3
- 210000004027 cell Anatomy 0.000 claims description 57
- 210000005260 human cell Anatomy 0.000 claims description 52
- 241001465754 Metazoa Species 0.000 claims description 46
- 206010028980 Neoplasm Diseases 0.000 claims description 14
- 238000000338 in vitro Methods 0.000 claims description 14
- 230000000050 nutritive effect Effects 0.000 claims description 9
- 239000000411 inducer Substances 0.000 claims description 6
- 235000015097 nutrients Nutrition 0.000 claims description 4
- 241000700605 Viruses Species 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 3
- 239000003226 mitogen Substances 0.000 claims description 3
- 102000016605 B-Cell Activating Factor Human genes 0.000 claims description 2
- 108010028006 B-Cell Activating Factor Proteins 0.000 claims description 2
- 230000009471 action Effects 0.000 claims description 2
- 210000004185 liver Anatomy 0.000 claims description 2
- 108020004707 nucleic acids Proteins 0.000 claims description 2
- 102000039446 nucleic acids Human genes 0.000 claims description 2
- 150000007523 nucleic acids Chemical class 0.000 claims description 2
- 210000005259 peripheral blood Anatomy 0.000 claims description 2
- 239000011886 peripheral blood Substances 0.000 claims description 2
- 210000000952 spleen Anatomy 0.000 claims description 2
- 210000004754 hybrid cell Anatomy 0.000 claims 2
- 201000009030 Carcinoma Diseases 0.000 claims 1
- 210000004727 amygdala Anatomy 0.000 claims 1
- 210000004072 lung Anatomy 0.000 claims 1
- 201000005789 splenic abscess Diseases 0.000 claims 1
- 238000002054 transplantation Methods 0.000 description 8
- 239000002609 medium Substances 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 6
- 241000700159 Rattus Species 0.000 description 5
- 210000001124 body fluid Anatomy 0.000 description 5
- 238000009792 diffusion process Methods 0.000 description 5
- 238000003306 harvesting Methods 0.000 description 5
- 230000008105 immune reaction Effects 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 108010062580 Concanavalin A Proteins 0.000 description 3
- 241000699800 Cricetinae Species 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 235000013601 eggs Nutrition 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 241000321096 Adenoides Species 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 241000711408 Murine respirovirus Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 239000012980 RPMI-1640 medium Substances 0.000 description 2
- 210000002534 adenoid Anatomy 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000007910 cell fusion Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 208000021550 spleen neoplasm Diseases 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 206010002199 Anaphylactic shock Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 208000010667 Carcinoma of liver and intrahepatic biliary tract Diseases 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000272201 Columbiformes Species 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 206010073069 Hepatic cancer Diseases 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 102000008072 Lymphokines Human genes 0.000 description 1
- 108010074338 Lymphokines Proteins 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- 108010047620 Phytohemagglutinins Proteins 0.000 description 1
- 235000009074 Phytolacca americana Nutrition 0.000 description 1
- 241001275115 Phytolacca bogotensis Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 229940088623 biologically active substance Drugs 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 230000003327 cancerostatic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 239000012510 hollow fiber Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000015788 innate immune response Effects 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 201000002250 liver carcinoma Diseases 0.000 description 1
- 201000005296 lung carcinoma Diseases 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000002741 palatine tonsil Anatomy 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000001885 phytohemagglutinin Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000013594 poultry meat Nutrition 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 210000004989 spleen cell Anatomy 0.000 description 1
- 230000003393 splenic effect Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Transplantation (AREA)
- General Engineering & Computer Science (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57019560A JPS58138395A (ja) | 1982-02-12 | 1982-02-12 | ヒト免疫応答抑制因子の製造方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH661745A5 true CH661745A5 (fr) | 1987-08-14 |
Family
ID=12002686
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH805/83A CH661745A5 (fr) | 1982-02-12 | 1983-02-14 | Application d'un procede a la production de suppresseur de reponse immunitaire humain. |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JPS58138395A (enrdf_load_stackoverflow) |
| KR (1) | KR900005860B1 (enrdf_load_stackoverflow) |
| CH (1) | CH661745A5 (enrdf_load_stackoverflow) |
| FR (1) | FR2521588B1 (enrdf_load_stackoverflow) |
| GB (1) | GB2118560B (enrdf_load_stackoverflow) |
| IT (1) | IT1167074B (enrdf_load_stackoverflow) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS609795B2 (ja) * | 1980-12-11 | 1985-03-13 | 株式会社林原生物化学研究所 | ヒト上皮細胞成長因子の製造方法 |
| JPS63126897A (ja) * | 1986-05-02 | 1988-05-30 | Yoshitomi Pharmaceut Ind Ltd | 免疫抑制因子 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2016015B (en) * | 1978-01-22 | 1982-05-06 | Hayashibara Co | Method of preparing interferon and preparations containing interferon |
| JPS6045848B2 (ja) * | 1980-07-31 | 1985-10-12 | 株式会社林原生物化学研究所 | ヒト成長ホルモンの製造方法 |
| JPS5729294A (en) * | 1980-07-30 | 1982-02-17 | Hayashibara Biochem Lab Inc | Preparation of human insulin |
-
1982
- 1982-02-12 JP JP57019560A patent/JPS58138395A/ja active Granted
-
1983
- 1983-02-03 KR KR1019830000414A patent/KR900005860B1/ko not_active Expired
- 1983-02-10 IT IT47689/83A patent/IT1167074B/it active
- 1983-02-11 FR FR8302180A patent/FR2521588B1/fr not_active Expired
- 1983-02-11 GB GB08303870A patent/GB2118560B/en not_active Expired
- 1983-02-14 CH CH805/83A patent/CH661745A5/fr not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FR2521588A1 (fr) | 1983-08-19 |
| IT1167074B (it) | 1987-05-06 |
| GB8303870D0 (en) | 1983-03-16 |
| GB2118560A (en) | 1983-11-02 |
| JPS58138395A (ja) | 1983-08-17 |
| GB2118560B (en) | 1985-06-05 |
| FR2521588B1 (fr) | 1985-10-25 |
| KR840003419A (ko) | 1984-09-08 |
| IT8347689A0 (it) | 1983-02-10 |
| JPH0214038B2 (enrdf_load_stackoverflow) | 1990-04-05 |
| KR900005860B1 (ko) | 1990-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH649786A5 (fr) | Production de facteur leucopoietique humain. | |
| CH650024A5 (fr) | Procede pour la production d'erythropoietine humaine. | |
| CH650801A5 (fr) | Procede pour preparer de l'interferon de type ii et preparation contenant de l'interferon de type ii. | |
| CH637831A5 (fr) | Procede de preparation d'interferon et preparation le contenant. | |
| CH650023A5 (fr) | Production d'hormone humaine stimulant les follicules. | |
| CH649785A5 (fr) | Production d'hormone luteinisante humaine. | |
| FR2495635A1 (fr) | Production d'urokinase humaine | |
| CH649782A5 (fr) | Procede pour la production d'insuline humaine. | |
| FR2556220A1 (fr) | Nouveau lymphokine et anticorps monoclonal specifique de ce lymphokine, leur production et leurs utilisations | |
| CH649784A5 (fr) | Procede pour la production de gonadotrophine chorionique humaine. | |
| CH650802A5 (fr) | Production d'hormone de croissance humaine. | |
| CH661745A5 (fr) | Application d'un procede a la production de suppresseur de reponse immunitaire humain. | |
| FR2615737A1 (fr) | Preparation et utilisation d'interferon-gamma | |
| CH652750A5 (fr) | Production de facteur de croissance humain. | |
| CH652749A5 (fr) | Production de calcitonine humaine. | |
| CH652748A5 (fr) | Production d'hormone parathyroidienne humaine. | |
| CH652745A5 (fr) | Procede pour la production d'hormone adrenocorticotrope humaine. | |
| CH658668A5 (fr) | Procede pour la production de kallikreine humaine. | |
| FR2523155A1 (fr) | Preparation de facteur de croissance des cellules t humaines | |
| JPS5823793A (ja) | ヒトｔ細胞増殖因子の製造方法 | |
| BE873594A (fr) | Interferon et preparation le contenant | |
| FR2497101A1 (fr) | Production d'hormone stimulation de la thyroide humaine | |
| CH651588A5 (en) | Preparation of human T cell growth factor | |
| CH649783A5 (fr) | Procede pour la production de prolactine humaine. | |
| FR2496466A1 (fr) | Production d'hormone lactogene, placentaire, humaine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |